CBDa (cannabidiol acid) is one of over one hundred cannabinoids present in cannabis. From it, as a result of temperature influence, CBD is formed, where it is transformed during heating. The process of converting CBDA to CBD is called decarboxylation. CBDa is considered a small cannabinoid and is only a small part of the overall cannabinoid profile. CBDA quality tests are rare, and most of them focus on the effects of CBD and not on the acid form of the molecule. However, many scientists have begun to study the therapeutic potential of this cannabinoid. Cannabidiol acid (CBDA) has no narcotic effect after ingestion.
CBDa has anti-inflammatory, anti-proliferative and anti-cancer properties. Anti-inflammatory CBDa activity is associated with the inhibition of cyclooxygenase, which is essential for the proper functioning of the circulatory and digestive systems.CBDa inhibits the COX-2 enzyme, which is secreted by breast cancer cells and is mentioned as one of the factors causing the formation of metastases. CBDa has a bactericidal effect and also inhibits the contraction of the gastrointestinal muscles, thus preventing nausea and vomiting, both as a result of chemotherapy and motion sickness.
CBDa preparations can be consumed by anyone. They are recommended to all those who want to supplement the deficiency of cannabinoids in their body and improve its general functioning, including its homeostasis or immunity.
It is worth noting that the higher the concentration of the extract, the stronger its effect.